IONIS PHARMACEUT reported $199.42M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Arrowhead Research ARWR:US $ 110.25M 19.49M
Astellas Pharma 4503:JP 317.56B 56.13B
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Exelixis EXEL:US $ 272.74M 61.76M
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Moderna Inc MRNA:US 1.84B 38M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M